Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice - Test2 - elhamkhani - TriplyDB

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

http://www.wikidata.org/entity/Q24681736

about

Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy Transmission and spreading of tauopathy in transgenic mouse brain Insights into Mechanisms of Chronic Neurodegeneration Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease Body fluid biomarkers in Alzheimer's disease Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau Nonhuman primate models of Alzheimer-like cerebral proteopathy Animal models for Alzheimer's disease and frontotemporal dementia: a perspective Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?Probing the biology of Alzheimer's disease in mice.Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.Tau, prions and Aβ: the triad of neurodegeneration.Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.Tau aggregation and its interplay with amyloid-β.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease Modes of Aβ toxicity in Alzheimer's disease.Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction.Trans-cellular propagation of Tau aggregation by fibrillar species Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in mice.Can infections cause Alzheimer's disease?Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration.Tau imaging in neurodegenerative diseases.Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.Brain homogenates from human tauopathies induce tau inclusions in mouse brain β-Amyloid oligomers in aging and Alzheimer's disease.Neuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.

P2860

Q21284823-1E461C3B-2C5B-45D2-8955-22589B549752 Q22251077-E6340515-EA56-472D-A949-2227DF3B7683 Q24651334-9BA7E8C7-BA2A-497B-8468-AC03907513A7 Q26771732-AC763486-C90A-4F81-B111-00FA8A9C9B36 Q26773154-2E700768-2A3A-46A8-BB32-5B03AAD507BD Q26830098-DAF37582-CF95-4355-A2FC-911DB5521734 Q26850298-F2BA290E-671A-4825-93D4-758AF07E2393 Q28081849-A63C0350-D0B3-4553-9E83-EE20895ED402 Q28535293-EA5030B9-4687-4C0C-91AB-0B3D37813647 Q28728135-25763C4D-843F-4897-B16F-9F4FE40165FD Q28749702-D13DC5EC-174E-4968-8289-259D5ED2D1AF Q30444295-E956DE1F-92C1-4D60-A1A2-FB6FC6A0141E Q33842635-4AD0E27B-A9E0-4A33-9743-1017CD319166 Q33876147-04ED24FE-58EA-498B-BC28-503EA3AEAD5F Q34157427-F4B96076-8185-406A-8551-037633BFF214 Q34206962-2FEA3907-EC03-40A9-AE18-93842A69CDFF Q34344718-9FA8BA7C-54B4-441F-9DAA-A7C200C6FC87 Q34374743-C4C69BE4-7424-4CC4-B22F-B8912D15BBF4 Q34438376-287F1CFA-06B1-4B0E-9B05-AC3FA553092D Q34463061-99ED3D00-518B-4BC2-A288-D3D85C0D83A7 Q34631209-A8679F82-514F-46BF-AEED-D740B97852F5 Q35008256-27AC1147-F9F8-4E86-88DF-0A87882015A9 Q35127516-6965CB06-8D8B-4336-B4F9-3F395279F203 Q35212180-298F202E-A969-4E6E-A2B1-EFBA730D5DD7 Q35223831-9C09E335-3539-42F4-B818-9400A5093442 Q35235869-BE1469BC-CAC2-4C3C-89F5-B11BCD0573EC Q35579318-D7B00629-7481-410C-9171-D2688AA2AF61 Q35951970-16EE637F-8496-47B5-9162-E7056A82CE67 Q35986968-54A2E59E-7D0F-4348-8A39-B1F56CC1ACEF Q36003836-696367A6-BF78-44F5-9DFF-60DA020A01F6 Q36437437-09F5CA8A-17C1-4AC7-9C92-5B76680CEA0D Q36449877-631DEC20-8505-450D-BD80-3CCDF303CFB1 Q36680395-5049AF30-19E0-451D-93BD-427187EB3C27 Q36688393-C3B9276B-4F6A-4D18-B4A4-3573CDA86103 Q36834567-317CD0C7-CEA6-4EBE-B8DF-7DBD40EAA92B Q36855702-E2B97DDA-1A84-474E-AE00-440175B042BF Q36915421-E93FD187-7B3A-419E-9F66-95E8C178846F Q36981528-28D693CB-899C-4C63-BE88-10F4E05F2071 Q36997912-C1663CC0-08BC-4D5D-B013-55412F2E2B1E Q37078850-6464979F-ADE9-4D5B-97BE-B7BB441C27D4

P2860

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

http://www.wikidata.org/entity/Q24681736

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@ast

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@en

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@nl

type

label

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@ast

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@en

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@nl

prefLabel

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@ast

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@en

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@nl

P1433

Q24681736-FA62CA97-8217-4E17-A561-C126D9B62365

P1476

Q24681736-5AE15056-2D26-4920-9F51-4CF45700F670

P2093

Q24681736-039B44CE-B150-48F8-B42C-6B9025265247

Q24681736-408AFB85-293B-41A9-B620-3AD1285F481A

Q24681736-8262B9D2-6049-4A93-9A14-B6DEEBF9F125

Q24681736-9E01B76E-44D5-40A5-BC90-A89CD91FF933

Q24681736-CBFF092B-16CD-462F-94BE-FAB439210803

Q24681736-E1E5DB92-21D9-4C42-9151-7E45C0E3E3D0

P2860

Q24681736-0072318D-8713-46F0-979D-CA83904BE4E3

Q24681736-05FBD334-8124-4F4A-A419-E9B13D83E929

Q24681736-0DB9AE53-ABF3-46E8-9BCE-6F9D2DB1B226

Q24681736-12BBD7AC-F0D8-4D0D-A69D-ACA2D41CCFB7

Q24681736-18A4D392-6C28-49A9-B7A7-8EEFF0E7C310

Q24681736-29941080-B8CD-4163-8070-44D401A5E47D

Q24681736-2F125BEF-9195-4210-8018-C61440869E93

Q24681736-42EA2D18-1935-485D-B907-29EBB2B24675

Q24681736-48AE5F85-5B44-4C7A-B44C-20DB843C1384

Q24681736-54FFE1C2-46EC-454A-B88E-8DB12E99126C

P304

Q24681736-C8A76740-8124-4248-8149-30A4D82F9A0F

P31

Q24681736-AE65CAFA-11BA-471C-AD00-99EED9B0D4DB

P3181

Q24681736-B2C530EC-F6B0-43A9-AE15-080CFFFC81D7

P356

Q24681736-1290B596-6B0E-4CF8-9644-BE930C8ED996

P407

Q24681736-7AD67C16-7146-463B-AF03-07E2FC7EEDA3

P433

Q24681736-4DEA88E7-B45F-4A8A-AD31-649926013CAF

P478

Q24681736-B959C8AB-4F77-47BF-B513-2C704574CF02

P50

Q24681736-27318C2B-5730-40C5-9967-A852AC025A8B

Q24681736-7ECD1A35-827F-4425-825C-475D060D4DD2

Q24681736-ACFC10F3-99D0-4D2E-A765-E78D7EA8F9AB

Q24681736-E8B2F5C9-440A-4115-8187-4BDE1D1A7FE0

Q24681736-F45D3A20-CF17-4CBA-B717-B98D24C622EC

P577

Q24681736-66F2ADC6-6D08-45FB-91DF-70F9B001A410

P5875

Q24681736-0E05DCD4-B4DE-4CD4-8374-1CB253E32DD4

P698

Q24681736-07824405-61D0-4EBD-BC66-B3F3E22B9A31

P921

Q24681736-FD472231-E796-430A-937E-B35504946A1E

Q24681736-c0097910-a458-4e98-9c95-3a66b36abc6d

P932

Q24681736-C62250A1-CF5F-4D5D-AD96-84678E4D0040

P3181

P356

AJPATH.2007.070403

P1433

The American Journal of Pathology

P1476

Induction of tau pathology by ...... n in APP x Tau transgenic mice

@en

P2093

Florence Clavaguera

http://www.w3.org/2001/XMLSchema#string

Jada Lewis

http://www.w3.org/2001/XMLSchema#string

Markus Tolnay

http://www.w3.org/2001/XMLSchema#string

Mike Hutton

http://www.w3.org/2001/XMLSchema#string

Rebecca Radde

http://www.w3.org/2001/XMLSchema#string

Tristan Bolmont

http://www.w3.org/2001/XMLSchema#string

P2860

Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

Inflammation and Alzheimer's disease

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Neurovascular mechanisms of Alzheimer's neurodegeneration.

P304

2012-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2369402

http://www.w3.org/2001/XMLSchema#string

P356

10.2353/AJPATH.2007.070403

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Melanie Meyer-Luehmann

Martin C Herzig

Matthias Staufenbiel

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5791751

http://www.w3.org/2001/XMLSchema#string

P698

18055549

http://www.w3.org/2001/XMLSchema#string

P921

P932

2111123

http://www.w3.org/2001/XMLSchema#string